Table 2.
Methods for Recurrence Detection
| No. of patients | % patients | |
|---|---|---|
| Total number of patients | 210 | |
| Total number recurred | 115 | 55% |
| Recurred before 3 years | 101 | 48 % |
| Symptoms | 70 | 69 % |
| Physical exam | 9 | 8 % |
| Imaging | 15 | 15 % |
| CT | 13 | |
| MRI | 0 | |
| PET | 1 | |
| Ultrasound | 1 | |
| CXR | 5 | 5 % |
| Labs | 3 | 3 % |
| Died of melanoma | 70 | 69 % |
| Died of other causes | 1 | 1 % |
| Died of unknown cause | 1 | 1 % |
| Alive | 29 | 29 % |
| Unknown | 1 | 1 % |
| Recurred after 3 years | 12 | 6 % |
| Symptoms | 9 | 75 % |
| Physical exam | 2 | 17 % |
| Imaging | 0 | |
| CXR | 1 | 8 % |
| Died of melanoma | 4 | 33 % |
| Alive | 8 | 67 % |
| Recurred on 3-year imaging | 2 | 1 % |
| Died of melanoma | 2 | 100 % |
| Did not recur | 95 | 45 % |
| Alive | 86 | 91 % |
| Died of other causes | 8 | 8 % |
| Died of unknown cause | 1 | 1 % |
| Total (followed at BIDMC) | 210 | |
| Alive | 123 | 59 % |
| Died of melanoma | 76 | 36 % |
| Died of other causes | 9 | 4 % |
| Died of unknown cause | 2 | 1 % |